Literature DB >> 2748605

Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA.

D Zucker-Franklin1, Y Z Cao.   

Abstract

The pathogenesis of thrombocytopenia associated with human immunodeficiency virus (HIV) infection is not fully understood. Immune mechanisms provide a partial explanation but fail to account for a lack of compensatory megakaryocytosis, the rapid reversal after treatment with azidothymidine, and the ultrastructural aberrations seen in the megakaryocytes of patients with acquired immunodeficiency syndrome. Therefore, a direct effect of HIV on megakaryocytes was investigated. The bone marrow of HIV seropositive individuals was analyzed ultrastructurally, and the megakaryocytes of 10 thrombocytopenic patients were subjected to in situ hybridization with a HIV RNA probe. The structural aberrations in HIV megakaryocytes were distinct from those in HIV-negative immune thrombocytopenias, and the megakaryocytes of 10 of 10 patients examined by in situ hybridization unambiguously expressed viral RNA. Therefore, it is likely that direct infection of megakaryocytes with HIV-1 is one mechanism for the decrease in platelet production.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2748605      PMCID: PMC297669          DOI: 10.1073/pnas.86.14.5595

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.

Authors:  J D Lifson; M B Feinberg; G R Reyes; L Rabin; B Banapour; S Chakrabarti; B Moss; F Wong-Staal; K S Steimer; E G Engleman
Journal:  Nature       Date:  1986 Oct 23-29       Impact factor: 49.962

Review 2.  The entry of enveloped viruses into cells by endocytosis.

Authors:  M Marsh
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

Review 3.  Membrane fusion proteins of enveloped animal viruses.

Authors:  J White; M Kielian; A Helenius
Journal:  Q Rev Biophys       Date:  1983-05       Impact factor: 5.318

4.  Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization.

Authors:  M E Harper; L M Marselle; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

5.  Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.

Authors:  J S McDougal; M S Kennedy; J M Sligh; S P Cort; A Mawle; J K Nicholson
Journal:  Science       Date:  1986-01-24       Impact factor: 47.728

6.  Hematologic abnormalities in the acquired immune deficiency syndrome.

Authors:  J L Spivak; B S Bender; T C Quinn
Journal:  Am J Med       Date:  1984-08       Impact factor: 4.965

7.  Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP.

Authors:  C P Stahl; D Zucker-Franklin; T P McDonald
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

8.  Inhibition of Semliki forest virus penetration by lysosomotropic weak bases.

Authors:  A Helenius; M Marsh; J White
Journal:  J Gen Virol       Date:  1982-01       Impact factor: 3.891

9.  Thrombocytopoiesis--analysis by membrane tracer and freeze-fracture studies on fresh human and cultured mouse megakaryocytes.

Authors:  D Zucker-Franklin; S Petursson
Journal:  J Cell Biol       Date:  1984-08       Impact factor: 10.539

10.  Human megakaryocytes. I. Characterization of the membrane and cytoplasmic components of isolated marrow megakaryocytes.

Authors:  E M Rabellino; R L Nachman; N Williams; R J Winchester; G D Ross
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

View more
  29 in total

1.  Distinct human immunodeficiency virus strains in the bone marrow are associated with the development of thrombocytopenia.

Authors:  F Voulgaropoulou; B Tan; M Soares; B Hahn; L Ratner
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Expression of CD4 by human megakaryocytes.

Authors:  R S Basch; Y H Kouri; S Karpatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 3.  Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.

Authors:  Davide Gibellini; Alberto Clò; Silvia Morini; Anna Miserocchi; Cristina Ponti; Maria Carla Re
Journal:  World J Virol       Date:  2013-05-12

Review 4.  Virus receptors: implications for pathogenesis and the design of antiviral agents.

Authors:  L C Norkin
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

5.  Ovine aortic smooth muscle cells allow the replication of visna-maedi virus in vitro.

Authors:  C Leroux; G Cordier; I Mercier; J Chastang; M Lyon; G Quérat; T Greenland; R Vigne; J F Mornex
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Immune thrombocytopenic purpura might be an early hematologic manifestation of undiagnosed human immunodeficiency virus infection.

Authors:  Shih-Wei Lai; Hsien-Feng Lin; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Intern Emerg Med       Date:  2016-08-25       Impact factor: 3.397

7.  Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2.

Authors:  Chawaree Chaipan; Imke Steffen; Theodros Solomon Tsegaye; Stephanie Bertram; Ilona Glowacka; Yukinari Kato; Jan Schmökel; Jan Münch; Graham Simmons; Rita Gerardy-Schahn; Stefan Pöhlmann
Journal:  Retrovirology       Date:  2010-05-19       Impact factor: 4.602

Review 8.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

9.  Successful use of Plasma Preparation Tubes™ (PPTs) in the COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 test.

Authors:  Colleen S Kraft; José Nilo G Binongo; Eileen M Burd; Molly E Eaton; Cindy B McCloskey; Helen Fernandes; Charles E Hill; Angela M Caliendo
Journal:  J Clin Virol       Date:  2013-01-16       Impact factor: 3.168

10.  Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets.

Authors:  A M Beebe; N Dua; T G Faith; P F Moore; N C Pedersen; S Dandekar
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.